Synthon Chile

Our ultramodern multi-purpose drug product site in Chile contains highly advanced facilities varying from development to large-scale production of tablets and capsules. The plant has been GMP approved by both the Chilean and European health authorities and complements our Barcelona drug product facility in serving global markets in terms of production as well as R&D.

The site is highly sustainable and the first drug product manufacturing plant in Chile to obtain approval by an EU health authority to manufacture products for the EU market. With its 350 employees, the site handles over 50 different products (molecules/strengths) from both the local and Synthon's global portfolio.

go to Synthon Chile website
Synthon_Chile_4-dfedd2d9.jpg
Highly sustainable plant
  • Double façade partly hanging over 1,600 m2 pond allowing evaporated water to precipitate and be used for cooling
  • Resistant to earthquakes up to 9 on the Richter scale
  • LED technology for lighting 4,000 light tubes
  • 240 m2 solar panels fully catering to hot water requirements
Synthon_Chile_2-fdafcea0.JPG
Facts & figures

Conventional drug products capacity

  • 1,100 million tablets
  • 162 million capsules
  • 486 million film-coated tablets
  • 89 million blisters
  • 3.6 million tubes

High-containment plant

  • 300 million tablets
  • 100 million capsules
  • 102 million film-coated tablets
Synthon_Chile_5-74a28ac1.JPG
Where to find us

Synthon Chile Ltda.

El Castaño 145
Lampa
Santiago, Chile

T (+56) 2 24 99 08 00
E contacto.cl@synthon.com

     Share this page